第95回日本細菌学会総会

講演情報

オンデマンド口頭発表

[ODP2] 1. 分類・疫学・感染症-b. 疫学・分子疫学

[ODP-011] 北日本における血流感染由来MRSAの分子疫学

Meiji Soe Aung1,漆原 範子1,川口谷 充代1,伊藤 政彦2,幅寺 敏2,廣瀬 弥奈3,小林 宣道1 (1札幌医大・医・衛生,2札幌臨床検査センター,3北海道医療大・歯・小児歯科)


BACKGROUND: MRSA is one of the major leading causes of bloodstream infections (BSIs). This study was conducted to explore the molecular epidemiological characteristics of MRSA from BSIs in northern Japan.
METHODS: A total of 277 MRSA isolates were collected from blood samples of patients in medical facilities in Hokkaido, for a two-year period from August 2017. Genotypes, virulence factors/drug-resistance profile, and structure of SCCmec complex were analyzed by PCR and sequencing analysis.
RESULTS: The dominant genotype was SCCmec-IIa, coagulase genotype (coa) IIa, ST5/ST764/ST2389 (n=171, 61.7%), followed by SCCmec-IVa (n=78, 28.2%), and IVl (n=10, 3.6%). Among the MRSA-IVa, 5.1% (14 isolates) had genetic features identical to USA300 clone (ST8/coa-IIIa/spa-t008 having PVL genes in φSa2USA and ACME-I), while PVL/ACME-negative MRSA-IVa isolates were assigned into ‍coa-IIa/IIIa/VIIa/VIIb, with coa-VIIa/spa-t1784/ST1 being dominant. SCCmec-IVl isolates belonged to coa-IIIa/CC8, harboring spj. Spermidine N-acetyltransferase gene (speG), which is typically present in ACME-I of USA300 clone, was identified in two isolates, ACME-II’-positive ST764-MRSA-IIa and ACME-negative ST1-MRSA-IVa.
CONCLUSION: Our present study revealed clonal diversity in MRSA from BSI in northern Japan, with potential increase in prevalence of ST8-USA300 MRSA clones.